there are other clinical trials going on with other drugs showing good clinical results in the critically ill. We need these trials. While everyone here is blindly focusing on hydroxychloroquine good process is being made.
My point, which I should have stated instead of assuming the reader would make the connection, is that they are giving the new, more costly drug, preference over the partially proven cheap drug with political overtones.